4Burmester GR, Rubbert-Roth A, Cantagrel A, et al. A randomised, double-blind,parallel-group study of the safety and efficacy of subcutaneous tocilizumab versus intravenous tocilizumab in com- bination with traditional disease-modifying antirheumatic drugs in patients with moderate to severe rheumatoid arthritis (SUMMACTA study) [J]. Ann Rheum Dis, 2014,73 ( 1 ) :69-74.
5Briggs S, Smith S, Ritchie S, et al. Late-onset bolus intravenous beta-lactam antibiotic adverse reaction:short-lived symptoms during drug administration and associated laboratory abnormali- ties[J]. Scand J Infect Dis ,2014,46( 1 ) : 14-20.
